BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 10, 2012
View Archived Issues
GSK patents new transient receptor potential TRPV1 channel antagonists
Read More
Novel cyclopropylamines presented by Oryzon Genomics
Read More
Purdue Pharma develops novel sodium channel antagonists
Read More
Cadila Healthcare discovers novel GPR119 receptor agonists
Read More
AC Immune and Belgian KUL design new products for tau-related disorders
Read More
Novel anticancer compounds synthesized at Nerviano Medical Sciences
Read More
Ongoing ARVO meeting features phase II results on ACU-4429 in AMD
Read More
Galderma submits reply to FDA for Pliaglis sNDA
Read More
Toll-like receptor antagonist active in autoimmune disease models
Read More
New Kyowa Hakko Kirin product demonstrates anticancer activity
Read More
Further phase III data reported on SNRI for depression
Read More
Seattle Genetics molecule inhibits fucosylation in vitro and in vivo
Read More
Aeras and CanSino enter collaboration to advance TB vaccine candidate
Read More
ImmunoCellular Therapeutics advances phase II ICT-107 trial
Read More
Novavax launches new phase I trial of VLP A/H5N1 flu vaccine candidate
Read More
Nuevolution receives milestone payment in collaboration
Read More
Evotec and 4-Antibody to collaborate on antibody screening and selection
Read More
Achillion kicks off phase I trial of second-generation pan-genotypic hepatitis C drug
Read More
FDA committee recommends approval of Pfizer product for RA
Read More
DARA BioSciences to advance neuropathic pain candidate
Read More
Resverlogix completes dosing in SUSTAIN study
Read More
New Xarelto sNDA submitted
Read More
Merck KGaA reports interim analysis from Erbitux adjuvant study
Read More
Transgene gives update on development of HPV vaccine candidate
Read More
Pluristem PLX cells effective in child with aplastic bone marrow
Read More